Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension

This study has been completed.
Sponsor:
Information provided by:
Regional Hospital Holstebro
ClinicalTrials.gov Identifier:
NCT00313430
First received: April 11, 2006
Last updated: February 28, 2010
Last verified: February 2010

April 11, 2006
February 28, 2010
May 2004
March 2008   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00313430 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension
Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease or Hypertension

The investigators want to test the hypothesis that patients with chronic renal disease have a poorer ability to preserve water after being thirsty and a poorer ability to excrete water after a load of fluid. They presume that these abilities become poorer when renal insufficiency progresses. The investigators further hypothesize that patients with hypertension also have a decreased ability to concentrate and dilute urine.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Healthy participants were recruited by advertisements in public and private institutions Patients with primary hypertension or chronic renal failure were recruited from the Out-patients' Clinic, Department of Medicine, Section of Nephrology, Holstebro Hospital

  • Renal Insufficiency, Chronic
  • Hypertension
Not Provided
Not Provided
Pedersen EB, Thomsen IM, Lauridsen TG. Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study. BMC Nephrol. 2010 Oct 5;11:26.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
Not Provided
March 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with chronic renal insufficiency, aged between 18 and 65, both men and women
  • Creatinine clearance between 30-59 ml/min
  • Patients with hypertension, aged between 18 and 65, both men and women; hypertension is defined as a mean arterial blood pressure in the daytime that is more than 140/90 mm Hg.
  • Healthy volunteers, aged between 18 and 65, both men and women

Exclusion Criteria:

  • Clinical signs or history of disease in the heart, lungs, liver, brain, and endocrine organs
  • Cancer
  • Alcohol abuse
  • Medicine abuse
  • Pregnancy
Both
18 Years to 65 Years
Not Provided
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00313430
MED. RES.HOS 2004 03/IT
Not Provided
Holstebro Hospital, Erling Bjerregaard Pedersen
Regional Hospital Holstebro
Not Provided
Study Chair: Erling B Pedersen, Professor Holstebro, Holstebro, Denmark
Regional Hospital Holstebro
February 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP